TargetHistone deacetylase 11(Homo sapiens (Human))
The Board Of Trustees Of The University Of Illinois
US Patent
The Board Of Trustees Of The University Of Illinois
US Patent
Affinity DataIC50: 746nMAssay Description:The effectiveness, or potency, of a present HDACI with respect to inhibiting the activity of an HDAC is measured by an IC50 value. The quantitative I...More data for this Ligand-Target Pair
TargetHistone deacetylase 11(Homo sapiens (Human))
The Board Of Trustees Of The University Of Illinois
US Patent
The Board Of Trustees Of The University Of Illinois
US Patent
Affinity DataIC50: 5.72E+3nMAssay Description:Inhibition of recombinant human HDAC11 expressed in HEK293T/17 cells using Boc-Lys(TFA)-AMC as substrate preincubated for 10 mins followed by substra...More data for this Ligand-Target Pair
TargetHistone deacetylase 11(Homo sapiens (Human))
The Board Of Trustees Of The University Of Illinois
US Patent
The Board Of Trustees Of The University Of Illinois
US Patent
Affinity DataIC50: 5.72E+3nMAssay Description:Inhibition of full length human recombinant HDAC11 using RHKKAc-AMC fluorogenic peptide as substrate incubated for 2 hrs by microplate reader assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 11(Homo sapiens (Human))
The Board Of Trustees Of The University Of Illinois
US Patent
The Board Of Trustees Of The University Of Illinois
US Patent
Affinity DataIC50: 5.72E+3nMAssay Description:Inhibition of full-length recombinant human HDAC11 using Boc-Lys(trifluoroacetyl)-AMC peptide as substrate by fluorescence based assayMore data for this Ligand-Target Pair
TargetHistone deacetylase 11(Homo sapiens (Human))
The Board Of Trustees Of The University Of Illinois
US Patent
The Board Of Trustees Of The University Of Illinois
US Patent
Affinity DataIC50: 6.00E+3nMAssay Description:Inhibition of human full length recombinant HDAC11 using p53 (379 to 382 residues) (RHKK(Ac)AMC) as substrate preincubated for 5 to 10 mins followed ...More data for this Ligand-Target Pair